• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人唾液酸(6-硫酸乳糖胺)树突状细胞是银屑病中的炎症性真皮树突状细胞,可驱动强烈的 TH17/TH1 T 细胞应答。

Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.

机构信息

Faculty of Medicine, Institute of Immunology, Technical University of Dresden, Dresden, Germany.

出版信息

J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9. doi: 10.1016/j.jaci.2010.12.009.

DOI:10.1016/j.jaci.2010.12.009
PMID:21377044
Abstract

BACKGROUND

Psoriasis is a chronic inflammatory skin disease that is considered to result from activated T cells stimulated by a population of inflammatory dermal dendritic cells (DCs). The origin and identity of these inflammatory dermal DCs are largely unknown.

OBJECTIVE

We previously identified slanDCs (6-sulfo LacNAc) DCs as a rich source of TNF-α and as the early major source of IL-12. Here we studied the relevance of slanDCs as inflammatory dermal DCs in psoriasis.

METHODS

Psoriasis skin samples were stained for the presence of activated slanDCs. Functional studies were carried out to determine the cytokine production of slanDCs, their T(h)17/T(h)1 T-cell programming, and their migration behavior.

RESULTS

Large numbers of IL-23, TNF-α, and inducible nitric oxide synthase expressing slanDCs were found in psoriatic skin samples, which can be recruited by C5a, CX3CL1, and CXCL12. SlanDCs isolated from blood produced high levels of IL-1ß, IL-23, IL-12, and IL-6. Compared with classic CD1c(+) DCs, slanDCs were far more powerful in programming T(h)17/T(h)1 T cells that secrete IL-17, IL-22, TNF-α, and IFN-γ, yet CD1c(+) DCs induced a higher IL-10 production of T cells. Self-nucleic acids complexed to cathelicidin LL37 trigger endosomal Toll-like receptor (TLR) signaling (TLR7, TLR8, TLR9) and are key factors for the activation of DCs in psoriasis. We show that slanDCs respond particularly well to complexes formed of self-RNA and LL37. Similarly, slanDCs stimulated with a synthetic TLR7/8 ligand produced high levels of proinflammatory cytokines.

CONCLUSION

Our study defines slanDCs as inflammatory dermal DCs in psoriasis and identifies their strong capacity to induce T(h)17/T(h)1 responses.

摘要

背景

银屑病是一种慢性炎症性皮肤病,被认为是由被炎症性真皮树突状细胞 (DC) 刺激的活化 T 细胞引起的。这些炎症性真皮 DC 的起源和身份在很大程度上是未知的。

目的

我们之前发现 slanDCs(6-硫酸乳糖酰神经氨酸)DC 是 TNF-α 的丰富来源,也是 IL-12 的早期主要来源。在这里,我们研究了 slanDCs 作为银屑病中炎症性真皮 DC 的相关性。

方法

对银屑病皮肤样本进行活化 slanDCs 的存在染色。进行功能研究以确定 slanDCs 的细胞因子产生、其 T(h)17/T(h)1 T 细胞编程和迁移行为。

结果

在银屑病皮肤样本中发现大量表达 IL-23、TNF-α 和诱导型一氧化氮合酶的 slanDCs,这些细胞可以被 C5a、CX3CL1 和 CXCL12 募集。从血液中分离的 slanDCs 产生高水平的 IL-1ß、IL-23、IL-12 和 IL-6。与经典的 CD1c(+) DC 相比,s lanDCs 在编程分泌 IL-17、IL-22、TNF-α 和 IFN-γ 的 T(h)17/T(h)1 T 细胞方面更强大,而 CD1c(+) DC 诱导 T 细胞产生更高水平的 IL-10。与抗菌肽 LL37 复合的自身核酸触发内体 Toll 样受体 (TLR) 信号 (TLR7、TLR8、TLR9),是银屑病中 DC 活化的关键因素。我们表明 slanDCs 对自身 RNA 和 LL37 形成的复合物特别敏感。同样,用合成 TLR7/8 配体刺激的 slanDCs 产生高水平的促炎细胞因子。

结论

我们的研究将 slanDCs 定义为银屑病中的炎症性真皮 DC,并确定其诱导 T(h)17/T(h)1 反应的强大能力。

相似文献

1
Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.人唾液酸(6-硫酸乳糖胺)树突状细胞是银屑病中的炎症性真皮树突状细胞,可驱动强烈的 TH17/TH1 T 细胞应答。
J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9. doi: 10.1016/j.jaci.2010.12.009.
2
The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.磷酸二酯酶4抑制剂阿普司特抑制Th1反应,但促进由6-磺酸乳糖胺(slan)树突状细胞诱导的Th17反应。
J Dermatol Sci. 2017 Aug;87(2):110-115. doi: 10.1016/j.jdermsci.2017.04.005. Epub 2017 Apr 20.
3
Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.慢性特应性皮炎和银屑病患者皮损树突状细胞具有平行激活 T 细胞亚群的能力。
J Allergy Clin Immunol. 2011 Sep;128(3):574-82.e1-12. doi: 10.1016/j.jaci.2011.05.016. Epub 2011 Jun 25.
4
Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.人 6-硫酸神经氨酸糖(sLan)树突状细胞是稳态和炎症皮肤树突状细胞的主要群体。
Clin Exp Dermatol. 2012 Mar;37(2):169-76. doi: 10.1111/j.1365-2230.2011.04213.x. Epub 2011 Dec 20.
5
Psoriasis in humans is associated with down-regulation of galectins in dendritic cells.人类银屑病与树突状细胞中半乳糖凝集素的下调有关。
J Pathol. 2012 Oct;228(2):193-203. doi: 10.1002/path.3996. Epub 2012 Mar 22.
6
Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.用二甲基富马酸控制 6-硫酸乳糖胺(sLan)树突状细胞的促炎功能。
J Dermatol Sci. 2017 Sep;87(3):278-284. doi: 10.1016/j.jdermsci.2017.06.016. Epub 2017 Jun 24.
7
Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.人类 6-硫酸神经氨酸乳糖(sLan)树突状细胞具有红斑狼疮中一种重要促炎细胞类型的分子和功能特征。
J Autoimmun. 2013 Feb;40:1-8. doi: 10.1016/j.jaut.2012.07.005. Epub 2012 Aug 11.
8
Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.接受依那西普治疗的银屑病患者皮损中炎症性唾液酸(6-硫酸神经氨酸)树突状细胞减少。
Exp Dermatol. 2013 Aug;22(8):535-40. doi: 10.1111/exd.12190.
9
Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.花粉衍生的低分子量因子抑制 6-硫酸化 LacNAc+树突状细胞诱导 T 辅助型 1 反应的能力。
Clin Exp Allergy. 2010 Feb;40(2):269-78. doi: 10.1111/j.1365-2222.2009.03369.x.
10
Myeloid but not plasmacytoid blood DCs possess Th1 polarizing and Th1/Th17 recruiting capacity in psoriasis.在银屑病中,髓系而非浆细胞样血 DC 具有 Th1 极化和募集 Th1/Th17 的能力。
Immunol Lett. 2017 Sep;189:109-113. doi: 10.1016/j.imlet.2017.04.005. Epub 2017 Apr 13.

引用本文的文献

1
Skin immune microenvironment in psoriasis: from bench to bedside.银屑病中的皮肤免疫微环境:从实验台到临床
Front Immunol. 2025 Aug 29;16:1643418. doi: 10.3389/fimmu.2025.1643418. eCollection 2025.
2
CCR7 dendritic cells expressing both IL-23A and IL-12B potentially contribute to psoriasis relapse.同时表达IL-23A和IL-12B的CCR7树突状细胞可能导致银屑病复发。
Nat Commun. 2025 Aug 15;16(1):7581. doi: 10.1038/s41467-025-62874-9.
3
Psoriasis.银屑病
Nat Rev Dis Primers. 2025 Jun 26;11(1):45. doi: 10.1038/s41572-025-00630-5.
4
Psoriasis: Immunological and genetic blueprints driving pathogenesis and potential for personalized therapies.银屑病:驱动发病机制的免疫学和遗传学蓝图以及个性化治疗的潜力。
Iran J Basic Med Sci. 2025;28(6):680-690. doi: 10.22038/ijbms.2025.85335.18442.
5
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review.用于银屑病的新一代抗白细胞介素-17药物:管线综述
Am J Clin Dermatol. 2025 May;26(3):307-320. doi: 10.1007/s40257-025-00928-w. Epub 2025 Feb 21.
6
Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments.银屑病:揭示疾病机制与推进药理学和纳米技术治疗
J Inflamm Res. 2025 Feb 10;18:2045-2072. doi: 10.2147/JIR.S506103. eCollection 2025.
7
Unveiling ferroptosis: a new frontier in skin disease research.揭示铁死亡:皮肤病研究的新前沿。
Front Immunol. 2024 Oct 4;15:1485523. doi: 10.3389/fimmu.2024.1485523. eCollection 2024.
8
Potential of resveratrol in the treatment of systemic lupus erythematosus (Review).白藜芦醇在治疗系统性红斑狼疮中的作用(综述)。
Mol Med Rep. 2024 Oct;30(4). doi: 10.3892/mmr.2024.13306. Epub 2024 Aug 19.
9
The Immunology of Psoriasis-Current Concepts in Pathogenesis.《银屑病的免疫学——发病机制的当前概念》。
Clin Rev Allergy Immunol. 2024 Apr;66(2):164-191. doi: 10.1007/s12016-024-08991-7. Epub 2024 Apr 20.
10
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets.银屑病上皮免疫微环境中的免疫细胞:新兴的治疗靶点。
Front Immunol. 2024 Jan 4;14:1340677. doi: 10.3389/fimmu.2023.1340677. eCollection 2023.